Objective:To compare the clinical efficacy of medication therapy and balloon eustachian tuboplasty plus tympanostomy tube insertion for chronic secretory otitis media.Methods:Sixty patients with chronic secretory otitis media treated in our hospital were included between November 2019 and March 2023 and divided into observational group and control group,in which patients received balloon eustachian tuboplasty(BET)plus tympanostomy tube insertion(TTI)and medication therapy respectively(both n=30).The pure tone audiometry(PTA),air-bone gap(ABG),and 7-item Eustachian Tube Dysfunction Questionnaire(ETDQ-7)scores were recorded in both groups.Results:The overall effective rate in the observational group was higher than that in the control group(100.00%vs.70.00%,P<0.01).The PTA,ABG and ETDQ-7 scores in both groups decreased sequentially before treatment,at 1 and 3 months after treatment(P<0.05).Conclusion:The clinical efficacy of BET plus TTI is favorable in the treatment of chronic secretory otitis media and it is worthy of clinical recommendation.
关键词
咽鼓管球囊扩张术/鼓膜置管/纯音听阈/慢性分泌性中耳炎
Key words
balloon eustachian tuboplasty/tympanostomy tube insertion/pure tone hearing threshold/chronic secretory otitis media
维普
万方数据